The customized kits are delivered every month based on a clinician-informed digital quiz, and are aligned with expert ...

Laura Bobolts, PharmD, BCOP, shares her perspective surrounding cost-effective analyses surrounding GI and esophageal cancers.

The data do, however, hint at the benefit of a more tailored approach focusing on groups with higher bleeding risks.

Subcutaneous infliximab (Remicade) proved safe and effective for active perianal Crohn's disease in a large multicenter ...

Routine Helicobacter pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding in patients hospitalised for myocardial infarction (MI), according to ...

Learn if post-heart attack H. pylori screening prevents gastrointestinal bleeding and who might benefit. Keep reading for ...

--Motus GI Holdings, Inc., a medical technology company focused on improving endoscopic outcomes and experiences, announced today that the Pure-Vu ® EVS Gastro was successfully used in the first ...

In patients with acute MI, upper gastrointestinal bleeding occurred in 1.5% within 1 year and was associated with poor outcomes, researchers reported at the European Society of Cardiology Congress ...

The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility and management of upper gastrointestinal bleeding not linked to varices ...

Pooled data show that no or shorter antibiotic prophylaxis for upper GI bleeding in cirrhosis is very likely noninferior to longer courses for all-cause mortality, challenging long-standing advice.

Summary Immunotherapy options for upper GI cancer are expanding rapidly, both in the types of medications available and the ways in which they can be administered.

The risk stratification tool shows a more than doubling of the rate of upper gastrointestinal cancer detections with about a 30% cost savings than universal screening in a study in China.